{"id": "1334460686118891520", "creation": 1606995195.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}, "quoted": "1334293148709818369", "text": "\u201c@AcuitasTx worked with @Moderna, another future #COVID19 #vaccine developer through the 2010s until Tekmira... terminated Acuitas\u2019 [drug delivery technology] license... Acuitas and Moderna parted ways but [Acuitas] developed... its own brand of [lipid nanoparticle].\u201d\ud83e\udd14 #IP https://t.co/XggOh2Ihhp", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#IP"]}